<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940705-2-00177</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=11 g=1 f=1 --> Section IV-C&hyph;1-b-(2)-(j). Adding new entries to the list of molecules toxic for  <!-- PJG 0012 frnewline --> vertebrates (see Appendix F); and  <!-- PJG 0012 frnewline --> Section IV-C&hyph;1-b-(2)-(k). Determining appropriate containment conditions for  <!-- PJG 0012 frnewline --> experiments according to case precedents developed under Section IV-C&hyph;1-b-(2)-(c).  <!-- PJG 0012 frnewline --> Section IV-C&hyph;1-b-(3). The NIH Director shall conduct, support, and assist training  <!-- PJG 0012 frnewline --> programs in laboratory safety for Institutional Biosafety Committee members,  <!-- PJG 0012 frnewline --> Biological Safety Officers, Principal Investigators, and laboratory staff.  <!-- PJG 0012 frnewline --> Section IV-C&hyph;2. Recombinant DNA Advisory Committee (RAC)  <!-- PJG 0012 frnewline --> The RAC is responsible for carrying out specified functions cited below as well as  <!-- PJG 0012 frnewline --> others assigned under its charter or by the DHHS Secretary, the DHHS Assistant  <!-- PJG 0012 frnewline --> Secretary for Health, and the NIH Director. The RAC consists of 25 members  <!-- PJG 0012 frnewline --> including the Chair, appointed by the DHHS Secretary or his/her designee, at least  <!-- PJG 0012 frnewline --> fourteen of whom are selected from authorities knowledgeable in the fields of  <!-- PJG 0012 frnewline --> molecular genetics, molecular biology, recombinant DNA research, or other  <!-- PJG 0012 frnewline --> scientific fields. At least six members of the RAC shall be persons knowledgeable  <!-- PJG 0012 frnewline --> in applicable law, standards of professional conduct and practice, public attitudes,  <!-- PJG 0012 frnewline --> the environment, public health, occupational health, or related fields.  <!-- PJG 0012 frnewline --> Representatives from Federal agencies shall serve as non-voting members.  <!-- PJG 0012 frnewline --> Nominations for the RAC may be submitted to the Office of Recombinant DNA  <!-- PJG 0012 frnewline --> Activities, National Institutes of Health, Building 31, Room 4B11, Bethesda,  <!-- PJG 0012 frnewline --> Maryland 20892, (301) 496&hyph;9838.  <!-- PJG 0012 frnewline --> All meetings of the RAC shall be announced in the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> , including  <!-- PJG 0012 frnewline --> tentative agenda items, 15 days before the meeting. Final agendas, if modified, shall  <!-- PJG 0012 frnewline --> be available at least 72 hours before the meeting. No item defined as a Major  <!-- PJG 0012 frnewline --> Action under Section IV-C&hyph;1-b-(1) may be added to an agenda following  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=4 --> Federal  <!-- PJG 0012 frnewline --> Register  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> publication.  <!-- PJG 0012 frnewline --> The RAC shall be responsible for advising the NIH Director on the actions listed in  <!-- PJG 0012 frnewline --> Sections IV-C&hyph;1-b-(1).  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> Section IV-C&hyph;3. Office of Recombinant DNA Activities (ORDA)  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ORDA shall serve as a focal point for information on recombinant DNA activities  <!-- PJG 0012 frnewline --> and provide advice to all within and outside NIH including institutions, Biological  <!-- PJG 0012 frnewline --> Safety Officers, Principal Investigators, Federal agencies, state and local  <!-- PJG 0012 frnewline --> governments, and institutions in the private sector. ORDA shall carry out such  <!-- PJG 0012 frnewline --> other functions as may be delegated to it by the NIH Director, including those  <!-- PJG 0012 frnewline --> authorities described in Section IV-C&hyph;1-b-(2). ORDA's responsibilities include, but  <!-- PJG 0012 frnewline --> are not limited to the following:  <!-- PJG 0012 frnewline --> Section IV-C&hyph;3-a. Reviewing and approving experiments in conjunction with ad hoc  <!-- PJG 0012 frnewline --> experts involving the cloning of genes encoding for toxin molecules that are lethal  <!-- PJG 0012 frnewline --> for vertebrates at an LD <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=2 --> 50 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  &gt;100 nanograms per kilogram body weight in organisms  <!-- PJG 0012 frnewline --> other than Escherichia coli K&hyph;12 (see Section III-B&hyph;1 and Appendices F-I and F-II);  <!-- PJG 0012 frnewline --> Section IV-C&hyph;3-b. Reviewing and approving certain experiments involving the  <!-- PJG 0012 frnewline --> deliberate transfer of recombinant DNA or DNA or RNA derived from  <!-- PJG 0012 frnewline --> recombinant DNA into one or more human subjects, in consultation with the RAC  <!-- PJG 0012 frnewline --> Chair and one or more RAC members, as necessary, that qualify for the Accelerated  <!-- PJG 0012 frnewline --> Review process (see Section III-B&hyph;2);  <!-- PJG 0012 frnewline --> Section IV-C&hyph;3-c. Reviewing and approving minor changes to human gene transfer  <!-- PJG 0012 frnewline --> protocols approved under Sections III-A&hyph;2 and III-B&hyph;2, in consultation with the RAC  <!-- PJG 0012 frnewline --> Chair and one or more RAC members, as necessary;  <!-- PJG 0012 frnewline --> Section IV-C&hyph;3-d. Reviewing and approving the membership of an institution's  <!-- PJG 0012 frnewline --> Institutional Biosafety Committee, and where it finds the Institutional Biosafety  <!-- PJG 0012 frnewline --> Committee meets the requirements set forth in Section IV-B&hyph;2 will give its approval  <!-- PJG 0012 frnewline --> to the Institutional Biosafety Committee membership;  <!-- PJG 0012 frnewline --> Section IV-C&hyph;3-e. Publishing in the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> :  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            